APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sustained Release Ocular Drug Delivery Systems

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Sustained Release Ocular Drug Delivery Systems Market Analysis and Forecast 2026-2032

26 December 2025199 pages

Choose your research edition.

Industry ResearchSustained Release Ocular Drug Delivery Systems Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Sustained Release Ocular Drug Delivery Systems Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Sustained Release Ocular Drug Delivery Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sustained Release Ocular Drug Delivery Systems Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Sustained Release Ocular Drug Delivery Systems Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sustained Release Ocular Drug Delivery Systems market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sustained Release Ocular Drug Delivery Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Sustained Release Ocular Drug Delivery Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Sustained Release Ocular Drug Delivery Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Sustained Release Ocular Drug Delivery Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Sustained Release Ocular Drug Delivery Systems include Aciont Inc., Allergan, Envisia Therapeutics, GrayBug, Icon Bioscience, Innocore Pharmaceuticals, Neurotech Pharmaceuticals, Ocular Therapeutix and OHR Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sustained Release Ocular Drug Delivery Systems, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Sustained Release Ocular Drug Delivery Systems, also provides the sales of main regions and countries. Of the upcoming market potential for Sustained Release Ocular Drug Delivery Systems, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sustained Release Ocular Drug Delivery Systems sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sustained Release Ocular Drug Delivery Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sustained Release Ocular Drug Delivery Systems sales, projected growth trends, production technology, application and end-user industry.

Sustained Release Ocular Drug Delivery Systems Segment by Company

Aciont Inc.

Allergan

Envisia Therapeutics

GrayBug

Icon Bioscience

Innocore Pharmaceuticals

Neurotech Pharmaceuticals

Ocular Therapeutix

OHR Pharmaceuticals

PolyActiva

pSivida

TheraKine

Santen Pharmaceutical

Sustained Release Ocular Drug Delivery Systems Segment by Type

Microcapsules/Nanocapsules

Microspheres/Nanosptheres

Liposome

Implants

Sustained Release Ocular Drug Delivery Systems Segment by Application

Glaucoma

Corneal Transplantation

Cataract

Others

Sustained Release Ocular Drug Delivery Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sustained Release Ocular Drug Delivery Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sustained Release Ocular Drug Delivery Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sustained Release Ocular Drug Delivery Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Sustained Release Ocular Drug Delivery Systems in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Sustained Release Ocular Drug Delivery Systems manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sustained Release Ocular Drug Delivery Systems sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Microcapsules/Nanocapsules Major Manufacturers Table 3. Microspheres/Nanosptheres Major Manufacturers Table 4. Liposome Major Manufacturers Table 5. Implants Major Manufacturers Table 6. Global Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Glaucoma Major Manufacturers Table 8. Corneal Transplantation Major Manufacturers Table 9. Cataract Major Manufacturers Table 10. Others Major Manufacturers Table 11. Sustained Release Ocular Drug Delivery Systems Industry Trends Table 12. Sustained Release Ocular Drug Delivery Systems Industry Drivers Table 13. Sustained Release Ocular Drug Delivery Systems Industry Opportunities and Challenges Table 14. Sustained Release Ocular Drug Delivery Systems Industry Restraints Table 15. Global Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2021-2026) Table 19. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2027-2032) Table 20. Global Sustained Release Ocular Drug Delivery Systems Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 21. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2021-2026) & (W Units) Table 22. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2027-2032) & (W Units) Table 23. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2021-2026) Table 24. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2027-2032) Table 25. Global Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Sustained Release Ocular Drug Delivery Systems Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Manufacturers (2021-2026) Table 29. Global Sustained Release Ocular Drug Delivery Systems Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Sustained Release Ocular Drug Delivery Systems Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Sustained Release Ocular Drug Delivery Systems Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Sustained Release Ocular Drug Delivery Systems Manufacturers, Product Type & Application Table 33. Global Sustained Release Ocular Drug Delivery Systems Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Sustained Release Ocular Drug Delivery Systems by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Sustained Release Ocular Drug Delivery Systems Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2021-2026) Table 40. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2027-2032) Table 41. Global Sustained Release Ocular Drug Delivery Systems Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 42. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2021-2026) & (W Units) Table 43. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2027-2032) & (W Units) Table 44. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2021-2026) Table 45. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2027-2032) Table 46. Global Sustained Release Ocular Drug Delivery Systems Price by Type (2021-2026) & (US$/Unit) Table 47. Global Sustained Release Ocular Drug Delivery Systems Price by Type (2027-2032) & (US$/Unit) Table 48. Global Sustained Release Ocular Drug Delivery Systems Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2021-2026) Table 52. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2027-2032) Table 53. Global Sustained Release Ocular Drug Delivery Systems Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 54. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2021-2026) & (W Units) Table 55. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2027-2032) & (W Units) Table 56. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2021-2026) Table 57. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2027-2032) Table 58. Global Sustained Release Ocular Drug Delivery Systems Price by Application (2021-2026) & (US$/Unit) Table 59. Global Sustained Release Ocular Drug Delivery Systems Price by Application (2027-2032) & (US$/Unit) Table 60. Aciont Inc. Company Information Table 61. Aciont Inc. Business Overview Table 62. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product Portfolio Table 64. Aciont Inc. Recent Development Table 65. Allergan Company Information Table 66. Allergan Business Overview Table 67. Allergan Sustained Release Ocular Drug Delivery Systems Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Allergan Sustained Release Ocular Drug Delivery Systems Product Portfolio Table 69. Allergan Recent Development Table 70. Envisia Therapeutics Company Information Table 71. Envisia Therapeutics Business Overview Table 72. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product Portfolio Table 74. Envisia Therapeutics Recent Development Table 75. GrayBug Company Information Table 76. GrayBug Business Overview Table 77. GrayBug Sustained Release Ocular Drug Delivery Systems Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. GrayBug Sustained Release Ocular Drug Delivery Systems Product Portfolio Table 79. GrayBug Recent Development Table 80. Icon Bioscience Company Information Table 81. Icon Bioscience Business Overview Table 82. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product Portfolio Table 84. Icon Bioscience Recent Development Table 85. Innocore Pharmaceuticals Company Information Table 86. Innocore Pharmaceuticals Business Overview Table 87. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio Table 89. Innocore Pharmaceuticals Recent Development Table 90. Neurotech Pharmaceuticals Company Information Table 91. Neurotech Pharmaceuticals Business Overview Table 92. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio Table 94. Neurotech Pharmaceuticals Recent Development Table 95. Ocular Therapeutix Company Information Table 96. Ocular Therapeutix Business Overview Table 97. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product Portfolio Table 99. Ocular Therapeutix Recent Development Table 100. OHR Pharmaceuticals Company Information Table 101. OHR Pharmaceuticals Business Overview Table 102. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio Table 104. OHR Pharmaceuticals Recent Development Table 105. PolyActiva Company Information Table 106. PolyActiva Business Overview Table 107. PolyActiva Sustained Release Ocular Drug Delivery Systems Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. PolyActiva Sustained Release Ocular Drug Delivery Systems Product Portfolio Table 109. PolyActiva Recent Development Table 110. pSivida Company Information Table 111. pSivida Business Overview Table 112. pSivida Sustained Release Ocular Drug Delivery Systems Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. pSivida Sustained Release Ocular Drug Delivery Systems Product Portfolio Table 114. pSivida Recent Development Table 115. TheraKine Company Information Table 116. TheraKine Business Overview Table 117. TheraKine Sustained Release Ocular Drug Delivery Systems Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. TheraKine Sustained Release Ocular Drug Delivery Systems Product Portfolio Table 119. TheraKine Recent Development Table 120. Santen Pharmaceutical Company Information Table 121. Santen Pharmaceutical Business Overview Table 122. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product Portfolio Table 124. Santen Pharmaceutical Recent Development Table 125. North America Sustained Release Ocular Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 126. North America Sustained Release Ocular Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 127. North America Sustained Release Ocular Drug Delivery Systems Sales by Type (2021-2026) & (W Units) Table 128. North America Sustained Release Ocular Drug Delivery Systems Sales by Type (2027-2032) & (W Units) Table 129. North America Sustained Release Ocular Drug Delivery Systems Sales Price by Type (2021-2026) & (US$/Unit) Table 130. North America Sustained Release Ocular Drug Delivery Systems Sales Price by Type (2027-2032) & (US$/Unit) Table 131. North America Sustained Release Ocular Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 132. North America Sustained Release Ocular Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 133. North America Sustained Release Ocular Drug Delivery Systems Sales by Application (2021-2026) & (W Units) Table 134. North America Sustained Release Ocular Drug Delivery Systems Sales by Application (2027-2032) & (W Units) Table 135. North America Sustained Release Ocular Drug Delivery Systems Sales Price by Application (2021-2026) & (US$/Unit) Table 136. North America Sustained Release Ocular Drug Delivery Systems Sales Price by Application (2027-2032) & (US$/Unit) Table 137. North America Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. North America Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. North America Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 141. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2021-2026) & (W Units) Table 142. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2027-2032) & (W Units) Table 143. North America Sustained Release Ocular Drug Delivery Systems Sales Price by Country (2021-2026) & (US$/Unit) Table 144. North America Sustained Release Ocular Drug Delivery Systems Sales Price by Country (2027-2032) & (US$/Unit) Table 145. United States Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 146. Canada Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 147. Mexico Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 148. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 149. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 150. Europe Sustained Release Ocular Drug Delivery Systems Sales by Type (2021-2026) & (W Units) Table 151. Europe Sustained Release Ocular Drug Delivery Systems Sales by Type (2027-2032) & (W Units) Table 152. Europe Sustained Release Ocular Drug Delivery Systems Sales Price by Type (2021-2026) & (US$/Unit) Table 153. Europe Sustained Release Ocular Drug Delivery Systems Sales Price by Type (2027-2032) & (US$/Unit) Table 154. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 155. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 156. Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2021-2026) & (W Units) Table 157. Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2027-2032) & (W Units) Table 158. Europe Sustained Release Ocular Drug Delivery Systems Sales Price by Application (2021-2026) & (US$/Unit) Table 159. Europe Sustained Release Ocular Drug Delivery Systems Sales Price by Application (2027-2032) & (US$/Unit) Table 160. Europe Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Europe Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. Europe Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 164. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2021-2026) & (W Units) Table 165. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2027-2032) & (W Units) Table 166. Europe Sustained Release Ocular Drug Delivery Systems Sales Price by Country (2021-2026) & (US$/Unit) Table 167. Europe Sustained Release Ocular Drug Delivery Systems Sales Price by Country (2027-2032) & (US$/Unit) Table 168. Germany Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 169. France Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 170. U.K. Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 171. Italy Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 172. Russia Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 173. Spain Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 174. Netherlands Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 175. Switzerland Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 176. Sweden Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 177. Poland Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 178. China Sustained Release Ocular Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 179. China Sustained Release Ocular Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 180. China Sustained Release Ocular Drug Delivery Systems Sales by Type (2021-2026) & (W Units) Table 181. China Sustained Release Ocular Drug Delivery Systems Sales by Type (2027-2032) & (W Units) Table 182. China Sustained Release Ocular Drug Delivery Systems Sales Price by Type (2021-2026) & (US$/Unit) Table 183. China Sustained Release Ocular Drug Delivery Systems Sales Price by Type (2027-2032) & (US$/Unit) Table 184. China Sustained Release Ocular Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 185. China Sustained Release Ocular Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 186. China Sustained Release Ocular Drug Delivery Systems Sales by Application (2021-2026) & (W Units) Table 187. China Sustained Release Ocular Drug Delivery Systems Sales by Application (2027-2032) & (W Units) Table 188. China Sustained Release Ocular Drug Delivery Systems Sales Price by Application (2021-2026) & (US$/Unit) Table 189. China Sustained Release Ocular Drug Delivery Systems Sales Price by Application (2027-2032) & (US$/Unit) Table 190. Asia Sustained Release Ocular Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 191. Asia Sustained Release Ocular Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 192. Asia Sustained Release Ocular Drug Delivery Systems Sales by Type (2021-2026) & (W Units) Table 193. Asia Sustained Release Ocular Drug Delivery Systems Sales by Type (2027-2032) & (W Units) Table 194. Asia Sustained Release Ocular Drug Delivery Systems Sales Price by Type (2021-2026) & (US$/Unit) Table 195. Asia Sustained Release Ocular Drug Delivery Systems Sales Price by Type (2027-2032) & (US$/Unit) Table 196. Asia Sustained Release Ocular Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 197. Asia Sustained Release Ocular Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 198. Asia Sustained Release Ocular Drug Delivery Systems Sales by Application (2021-2026) & (W Units) Table 199. Asia Sustained Release Ocular Drug Delivery Systems Sales by Application (2027-2032) & (W Units) Table 200. Asia Sustained Release Ocular Drug Delivery Systems Sales Price by Application (2021-2026) & (US$/Unit) Table 201. Asia Sustained Release Ocular Drug Delivery Systems Sales Price by Application (2027-2032) & (US$/Unit) Table 202. Asia Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. Asia Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. Asia Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. Asia Sustained Release Ocular Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 206. Asia Sustained Release Ocular Drug Delivery Systems Sales by Country (2021-2026) & (W Units) Table 207. Asia Sustained Release Ocular Drug Delivery Systems Sales by Country (2027-2032) & (W Units) Table 208. Asia Sustained Release Ocular Drug Delivery Systems Sales Price by Country (2021-2026) & (US$/Unit) Table 209. Asia Sustained Release Ocular Drug Delivery Systems Sales Price by Country (2027-2032) & (US$/Unit) Table 210. Japan Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 211. South Korea Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 212. India Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 213. Australia Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 214. Taiwan Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 215. Southeast Asia Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 216. SAMEA Sustained Release Ocular Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 217. SAMEA Sustained Release Ocular Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 218. SAMEA Sustained Release Ocular Drug Delivery Systems Sales by Type (2021-2026) & (W Units) Table 219. SAMEA Sustained Release Ocular Drug Delivery Systems Sales by Type (2027-2032) & (W Units) Table 220. SAMEA Sustained Release Ocular Drug Delivery Systems Sales Price by Type (2021-2026) & (US$/Unit) Table 221. SAMEA Sustained Release Ocular Drug Delivery Systems Sales Price by Type (2027-2032) & (US$/Unit) Table 222. SAMEA Sustained Release Ocular Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 223. SAMEA Sustained Release Ocular Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 224. SAMEA Sustained Release Ocular Drug Delivery Systems Sales by Application (2021-2026) & (W Units) Table 225. SAMEA Sustained Release Ocular Drug Delivery Systems Sales by Application (2027-2032) & (W Units) Table 226. SAMEA Sustained Release Ocular Drug Delivery Systems Sales Price by Application (2021-2026) & (US$/Unit) Table 227. SAMEA Sustained Release Ocular Drug Delivery Systems Sales Price by Application (2027-2032) & (US$/Unit) Table 228. SAMEA Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. SAMEA Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. SAMEA Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. SAMEA Sustained Release Ocular Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 232. SAMEA Sustained Release Ocular Drug Delivery Systems Sales by Country (2021-2026) & (W Units) Table 233. SAMEA Sustained Release Ocular Drug Delivery Systems Sales by Country (2027-2032) & (W Units) Table 234. SAMEA Sustained Release Ocular Drug Delivery Systems Sales Price by Country (2021-2026) & (US$/Unit) Table 235. SAMEA Sustained Release Ocular Drug Delivery Systems Sales Price by Country (2027-2032) & (US$/Unit) Table 236. Brazil Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 237. Argentina Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 238. Chile Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 239. Colombia Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 240. Peru Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 241. Saudi Arabia Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 242. Israel Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 243. UAE Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 244. Turkey Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 245. Iran Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 246. Egypt Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 247. Key Raw Materials Table 248. Raw Materials Key Suppliers Table 249. Sustained Release Ocular Drug Delivery Systems Distributors List Table 250. Sustained Release Ocular Drug Delivery Systems Customers List Table 251. Research Programs/Design for This Report Table 252. Authors List of This Report Table 253. Secondary Sources Table 254. Primary Sources List of Figures Figure 1. Sustained Release Ocular Drug Delivery Systems Image Figure 2. Global Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sustained Release Ocular Drug Delivery Systems Market Size Share 2021 VS 2025 VS 2032 Figure 4. Microcapsules/Nanocapsules Image Figure 5. Microspheres/Nanosptheres Image Figure 6. Liposome Image Figure 7. Implants Image Figure 8. Global Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Sustained Release Ocular Drug Delivery Systems Market Size Share 2021 VS 2025 VS 2032 Figure 10. Glaucoma Image Figure 11. Corneal Transplantation Image Figure 12. Cataract Image Figure 13. Others Image Figure 14. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Sustained Release Ocular Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Figure 16. Global Sustained Release Ocular Drug Delivery Systems Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2021-2032) Figure 19. Global Sustained Release Ocular Drug Delivery Systems Sales (2021-2032) & (W Units) Figure 20. Global Sustained Release Ocular Drug Delivery Systems Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 21. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Sustained Release Ocular Drug Delivery Systems Sales YoY (2021-2032) & (W Units) Figure 23. Europe Sustained Release Ocular Drug Delivery Systems Sales YoY (2021-2032) & (W Units) Figure 24. China Sustained Release Ocular Drug Delivery Systems Sales YoY (2021-2032) & (W Units) Figure 25. Asia (Excluding China) Sustained Release Ocular Drug Delivery Systems Sales YoY (2021-2032) & (W Units) Figure 26. South America, Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales YoY (2021-2032) & (W Units) Figure 27. Global Sustained Release Ocular Drug Delivery Systems Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Sustained Release Ocular Drug Delivery Systems Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2021-2032) Figure 33. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 34. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2021-2032) Figure 36. Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2021-2032) Figure 39. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 40. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2021-2032) Figure 42. North America Sustained Release Ocular Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 43. North America Sustained Release Ocular Drug Delivery Systems Sales Share by Type (2021-2032) Figure 44. North America Sustained Release Ocular Drug Delivery Systems Revenue Share by Application (2021-2032) Figure 45. North America Sustained Release Ocular Drug Delivery Systems Sales Share by Application (2021-2032) Figure 46. North America Sustained Release Ocular Drug Delivery Systems Revenue Share by Country (2021-2032) Figure 47. North America Sustained Release Ocular Drug Delivery Systems Sales Share by Country (2021-2032) Figure 48. Europe Sustained Release Ocular Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 49. Europe Sustained Release Ocular Drug Delivery Systems Sales Share by Type (2021-2032) Figure 50. Europe Sustained Release Ocular Drug Delivery Systems Revenue Share by Application (2021-2032) Figure 51. Europe Sustained Release Ocular Drug Delivery Systems Sales Share by Application (2021-2032) Figure 52. Europe Sustained Release Ocular Drug Delivery Systems Revenue Share by Country (2021-2032) Figure 53. Europe Sustained Release Ocular Drug Delivery Systems Sales Share by Country (2021-2032) Figure 54. China Sustained Release Ocular Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 55. China Sustained Release Ocular Drug Delivery Systems Sales Share by Type (2021-2032) Figure 56. China Sustained Release Ocular Drug Delivery Systems Revenue Share by Application (2021-2032) Figure 57. China Sustained Release Ocular Drug Delivery Systems Sales Share by Application (2021-2032) Figure 58. Asia Sustained Release Ocular Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 59. Asia Sustained Release Ocular Drug Delivery Systems Sales Share by Type (2021-2032) Figure 60. Asia Sustained Release Ocular Drug Delivery Systems Revenue Share by Application (2021-2032) Figure 61. Asia Sustained Release Ocular Drug Delivery Systems Sales Share by Application (2021-2032) Figure 62. Asia Sustained Release Ocular Drug Delivery Systems Revenue Share by Country (2021-2032) Figure 63. Asia Sustained Release Ocular Drug Delivery Systems Sales Share by Country (2021-2032) Figure 64. SAMEA Sustained Release Ocular Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 65. SAMEA Sustained Release Ocular Drug Delivery Systems Sales S

Scope & coverage.

Types
  • Microcapsules/Nanocapsules
  • Microspheres/Nanosptheres
  • Liposome
  • Implants
Applications
  • Glaucoma
  • Corneal Transplantation
  • Cataract
  • Others
Companies covered
  • Aciont Inc.
  • Allergan
  • Envisia Therapeutics
  • GrayBug
  • Icon Bioscience
  • Innocore Pharmaceuticals
  • Neurotech Pharmaceuticals
  • Ocular Therapeutix
  • OHR Pharmaceuticals
  • PolyActiva
  • pSivida
  • TheraKine
  • Santen Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Sustained Release Ocular Drug Delivery Systems Market by Type
  3. 1.2.1 Global Sustained Release Ocular Drug Delivery Systems Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Microcapsules/Nanocapsules
  5. 1.2.3 Microspheres/Nanosptheres
  6. 1.2.4 Liposome
  7. 1.2.5 Implants
  8. 1.3 Sustained Release Ocular Drug Delivery Systems Market by Application
  9. 1.3.1 Global Sustained Release Ocular Drug Delivery Systems Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Glaucoma
  11. 1.3.3 Corneal Transplantation
  12. 1.3.4 Cataract
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Sustained Release Ocular Drug Delivery Systems Market Dynamics
  1. 2.1 Sustained Release Ocular Drug Delivery Systems Industry Trends
  2. 2.2 Sustained Release Ocular Drug Delivery Systems Industry Drivers
  3. 2.3 Sustained Release Ocular Drug Delivery Systems Industry Opportunities and Challenges
  4. 2.4 Sustained Release Ocular Drug Delivery Systems Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Sustained Release Ocular Drug Delivery Systems Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Region
  3. 3.2.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2021-2026)
  5. 3.2.3 Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2027-2032)
  6. 3.2.4 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Sustained Release Ocular Drug Delivery Systems Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Sustained Release Ocular Drug Delivery Systems Sales by Region
  9. 3.4.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2021-2026)
  11. 3.4.3 Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2027-2032)
  12. 3.4.4 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturers
  2. 4.1.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Sustained Release Ocular Drug Delivery Systems Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Sustained Release Ocular Drug Delivery Systems Sales by Manufacturers
  6. 4.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Sustained Release Ocular Drug Delivery Systems Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Sustained Release Ocular Drug Delivery Systems Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Sustained Release Ocular Drug Delivery Systems Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Sustained Release Ocular Drug Delivery Systems Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Sustained Release Ocular Drug Delivery Systems Manufacturers, Product Type & Application
  13. 4.7 Global Sustained Release Ocular Drug Delivery Systems Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Sustained Release Ocular Drug Delivery Systems Market CR5 and HHI
  16. 4.8.2 2025 Sustained Release Ocular Drug Delivery Systems Tier 1, Tier 2, and Tier 3
5 Sustained Release Ocular Drug Delivery Systems Market by Type
  1. 5.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Type
  2. 5.1.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Sustained Release Ocular Drug Delivery Systems Sales by Type
  6. 5.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2021-2032)
  9. 5.3 Global Sustained Release Ocular Drug Delivery Systems Price by Type
6 Sustained Release Ocular Drug Delivery Systems Market by Application
  1. 6.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Application
  2. 6.1.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Sustained Release Ocular Drug Delivery Systems Sales by Application
  6. 6.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2021-2032)
  9. 6.3 Global Sustained Release Ocular Drug Delivery Systems Price by Application
7 Company Profiles
  1. 7.1 Aciont Inc.
  2. 7.1.1 Aciont Inc. Company Information
  3. 7.1.2 Aciont Inc. Business Overview
  4. 7.1.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product Portfolio
  6. 7.1.5 Aciont Inc. Recent Developments
  7. 7.2 Allergan
  8. 7.2.1 Allergan Company Information
  9. 7.2.2 Allergan Business Overview
  10. 7.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Product Portfolio
  12. 7.2.5 Allergan Recent Developments
  13. 7.3 Envisia Therapeutics
  14. 7.3.1 Envisia Therapeutics Company Information
  15. 7.3.2 Envisia Therapeutics Business Overview
  16. 7.3.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product Portfolio
  18. 7.3.5 Envisia Therapeutics Recent Developments
  19. 7.4 GrayBug
  20. 7.4.1 GrayBug Company Information
  21. 7.4.2 GrayBug Business Overview
  22. 7.4.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GrayBug Sustained Release Ocular Drug Delivery Systems Product Portfolio
  24. 7.4.5 GrayBug Recent Developments
  25. 7.5 Icon Bioscience
  26. 7.5.1 Icon Bioscience Company Information
  27. 7.5.2 Icon Bioscience Business Overview
  28. 7.5.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product Portfolio
  30. 7.5.5 Icon Bioscience Recent Developments
  31. 7.6 Innocore Pharmaceuticals
  32. 7.6.1 Innocore Pharmaceuticals Company Information
  33. 7.6.2 Innocore Pharmaceuticals Business Overview
  34. 7.6.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio
  36. 7.6.5 Innocore Pharmaceuticals Recent Developments
  37. 7.7 Neurotech Pharmaceuticals
  38. 7.7.1 Neurotech Pharmaceuticals Company Information
  39. 7.7.2 Neurotech Pharmaceuticals Business Overview
  40. 7.7.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio
  42. 7.7.5 Neurotech Pharmaceuticals Recent Developments
  43. 7.8 Ocular Therapeutix
  44. 7.8.1 Ocular Therapeutix Company Information
  45. 7.8.2 Ocular Therapeutix Business Overview
  46. 7.8.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product Portfolio
  48. 7.8.5 Ocular Therapeutix Recent Developments
  49. 7.9 OHR Pharmaceuticals
  50. 7.9.1 OHR Pharmaceuticals Company Information
  51. 7.9.2 OHR Pharmaceuticals Business Overview
  52. 7.9.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio
  54. 7.9.5 OHR Pharmaceuticals Recent Developments
  55. 7.10 PolyActiva
  56. 7.10.1 PolyActiva Company Information
  57. 7.10.2 PolyActiva Business Overview
  58. 7.10.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 PolyActiva Sustained Release Ocular Drug Delivery Systems Product Portfolio
  60. 7.10.5 PolyActiva Recent Developments
  61. 7.11 pSivida
  62. 7.11.1 pSivida Company Information
  63. 7.11.2 pSivida Business Overview
  64. 7.11.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 pSivida Sustained Release Ocular Drug Delivery Systems Product Portfolio
  66. 7.11.5 pSivida Recent Developments
  67. 7.12 TheraKine
  68. 7.12.1 TheraKine Company Information
  69. 7.12.2 TheraKine Business Overview
  70. 7.12.3 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 TheraKine Sustained Release Ocular Drug Delivery Systems Product Portfolio
  72. 7.12.5 TheraKine Recent Developments
  73. 7.13 Santen Pharmaceutical
  74. 7.13.1 Santen Pharmaceutical Company Information
  75. 7.13.2 Santen Pharmaceutical Business Overview
  76. 7.13.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product Portfolio
  78. 7.13.5 Santen Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Sustained Release Ocular Drug Delivery Systems Market Size by Type
  2. 8.1.1 North America Sustained Release Ocular Drug Delivery Systems Revenue by Type (2021-2032)
  3. 8.1.2 North America Sustained Release Ocular Drug Delivery Systems Sales by Type (2021-2032)
  4. 8.1.3 North America Sustained Release Ocular Drug Delivery Systems Price by Type (2021-2032)
  5. 8.2 North America Sustained Release Ocular Drug Delivery Systems Market Size by Application
  6. 8.2.1 North America Sustained Release Ocular Drug Delivery Systems Revenue by Application (2021-2032)
  7. 8.2.2 North America Sustained Release Ocular Drug Delivery Systems Sales by Application (2021-2032)
  8. 8.2.3 North America Sustained Release Ocular Drug Delivery Systems Price by Application (2021-2032)
  9. 8.3 North America Sustained Release Ocular Drug Delivery Systems Market Size by Country
  10. 8.3.1 North America Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Sustained Release Ocular Drug Delivery Systems Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Sustained Release Ocular Drug Delivery Systems Market Size by Type
  2. 9.1.1 Europe Sustained Release Ocular Drug Delivery Systems Revenue by Type (2021-2032)
  3. 9.1.2 Europe Sustained Release Ocular Drug Delivery Systems Sales by Type (2021-2032)
  4. 9.1.3 Europe Sustained Release Ocular Drug Delivery Systems Price by Type (2021-2032)
  5. 9.2 Europe Sustained Release Ocular Drug Delivery Systems Market Size by Application
  6. 9.2.1 Europe Sustained Release Ocular Drug Delivery Systems Revenue by Application (2021-2032)
  7. 9.2.2 Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2021-2032)
  8. 9.2.3 Europe Sustained Release Ocular Drug Delivery Systems Price by Application (2021-2032)
  9. 9.3 Europe Sustained Release Ocular Drug Delivery Systems Market Size by Country
  10. 9.3.1 Europe Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Sustained Release Ocular Drug Delivery Systems Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Sustained Release Ocular Drug Delivery Systems Market Size by Type
  2. 10.1.1 China Sustained Release Ocular Drug Delivery Systems Revenue by Type (2021-2032)
  3. 10.1.2 China Sustained Release Ocular Drug Delivery Systems Sales by Type (2021-2032)
  4. 10.1.3 China Sustained Release Ocular Drug Delivery Systems Price by Type (2021-2032)
  5. 10.2 China Sustained Release Ocular Drug Delivery Systems Market Size by Application
  6. 10.2.1 China Sustained Release Ocular Drug Delivery Systems Revenue by Application (2021-2032)
  7. 10.2.2 China Sustained Release Ocular Drug Delivery Systems Sales by Application (2021-2032)
  8. 10.2.3 China Sustained Release Ocular Drug Delivery Systems Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Sustained Release Ocular Drug Delivery Systems Market Size by Type
  2. 11.1.1 Asia Sustained Release Ocular Drug Delivery Systems Revenue by Type (2021-2032)
  3. 11.1.2 Asia Sustained Release Ocular Drug Delivery Systems Sales by Type (2021-2032)
  4. 11.1.3 Asia Sustained Release Ocular Drug Delivery Systems Price by Type (2021-2032)
  5. 11.2 Asia Sustained Release Ocular Drug Delivery Systems Market Size by Application
  6. 11.2.1 Asia Sustained Release Ocular Drug Delivery Systems Revenue by Application (2021-2032)
  7. 11.2.2 Asia Sustained Release Ocular Drug Delivery Systems Sales by Application (2021-2032)
  8. 11.2.3 Asia Sustained Release Ocular Drug Delivery Systems Price by Application (2021-2032)
  9. 11.3 Asia Sustained Release Ocular Drug Delivery Systems Market Size by Country
  10. 11.3.1 Asia Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Sustained Release Ocular Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Sustained Release Ocular Drug Delivery Systems Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Sustained Release Ocular Drug Delivery Systems Market Size by Type
  2. 12.1.1 SAMEA Sustained Release Ocular Drug Delivery Systems Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Sustained Release Ocular Drug Delivery Systems Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Sustained Release Ocular Drug Delivery Systems Price by Type (2021-2032)
  5. 12.2 SAMEA Sustained Release Ocular Drug Delivery Systems Market Size by Application
  6. 12.2.1 SAMEA Sustained Release Ocular Drug Delivery Systems Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Sustained Release Ocular Drug Delivery Systems Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Sustained Release Ocular Drug Delivery Systems Price by Application (2021-2032)
  9. 12.3 SAMEA Sustained Release Ocular Drug Delivery Systems Market Size by Country
  10. 12.3.1 SAMEA Sustained Release Ocular Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Sustained Release Ocular Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Sustained Release Ocular Drug Delivery Systems Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Sustained Release Ocular Drug Delivery Systems Value Chain Analysis
  2. 13.1.1 Sustained Release Ocular Drug Delivery Systems Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Sustained Release Ocular Drug Delivery Systems Production Mode & Process
  6. 13.2 Sustained Release Ocular Drug Delivery Systems Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Sustained Release Ocular Drug Delivery Systems Distributors
  9. 13.2.3 Sustained Release Ocular Drug Delivery Systems Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst